| Dr Dana Allison Bleakney, MD | |
|
3600 Gaston Ave, Suite 454, Dallas, TX 75246-1800 | |
| (214) 820-8300 | |
| (214) 820-8313 |
| Full Name | Dr Dana Allison Bleakney |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 3600 Gaston Ave, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255368502 | NPI | - | NPPES |
| 8F3451 | Other | TX | BCBS |
| 080183897 | Other | TX | RR MEDICARE |
| 150357501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | L0988 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor University Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic dermatitis, more commonly known as eczema. Toxin-producing bacteria on the surface of our skin induces a protein that causes our own cells to react and cause inflammation.
Healthy white blood cells, called "T-cells," play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, M.D., Ph.D., that was published in Cell Reports.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.
› Verified 5 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic dermatitis, more commonly known as eczema. Toxin-producing bacteria on the surface of our skin induces a protein that causes our own cells to react and cause inflammation.
Healthy white blood cells, called "T-cells," play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, M.D., Ph.D., that was published in Cell Reports.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Allison Bleakney, MD 3600 Gaston Ave, Barnett Tower, Suite 1109, Dallas, TX 75246-1800 Ph: (214) 820-8300 | Dr Dana Allison Bleakney, MD 3600 Gaston Ave, Suite 454, Dallas, TX 75246-1800 Ph: (214) 820-8300 |
News Archive
Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic dermatitis, more commonly known as eczema. Toxin-producing bacteria on the surface of our skin induces a protein that causes our own cells to react and cause inflammation.
Healthy white blood cells, called "T-cells," play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, M.D., Ph.D., that was published in Cell Reports.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.
› Verified 5 days ago
Dr. Juan F Quiroz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4811a Columbia Ave, Dallas, TX 75226 Phone: 214-823-5590 Fax: 214-823-6638 | |
Dr. Michelle Dobbs, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6333 E Mockingbird Ln, Suite 126, Dallas, TX 75214 Phone: 214-826-6005 | |
Howard J Huntzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9250 Amberton Pkwy, Dallas, TX 75243 Phone: 682-236-3656 | |
Robert J Dimeff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8081 Walnut Hill Ln, Dallas, TX 75231 Phone: 214-750-1207 Fax: 214-739-5029 | |
Pardeep K Shori, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7012 La Vista Dr, Dallas, TX 75214 Phone: 817-564-5761 | |
Mary Elizabeth Wilcox Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 Fairmount St, Dallas, TX 75201 Phone: 214-742-9310 | |
Elizabeth Chapek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Phone: 214-341-8742 |